Lisa J Herrinton Liyan Liu Oren Abramson Elaine S Jaffe
10.1002/pds.2216
Pharmacoepidemiol Drug Saf
2012 Jan;21(1):49-52.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/21823196/
Liver Neoplasms / epidemiology Lymphoma, T-Cell, Peripheral / epidemiology Splenic Neoplasms / epidemiology Tumor Necrosis Factor-alpha / antagonists & inhibitors
Liver Neoplasms / epidemiology Lymphoma, T-Cell, Peripheral / epidemiology Splenic Neoplasms / epidemiology Tumor Necrosis Factor-alpha / antagonists & inhibitors Research Support, Non-U.S. Gov't Adult Aged California / epidemiology Cohort Studies Crohn Disease / drug therapy Crohn Disease / epidemiology Female HIV Infections / epidemiology Humans Incidence Liver Neoplasms / etiology Liver Neoplasms / pathology Lymphoma, T-Cell, Peripheral / etiology Lymphoma, T-Cell, Peripheral / pathology Male Managed Care Programs / statistics & numerical data Middle Aged Retrospective Studies Splenic Neoplasms / etiology Splenic Neoplasms / pathology Young Adult Tumor Necrosis Factor-alpha
PMC6324845
21823196
The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006
2012